IFNB1 and myeloid sarcoma: Type 1 interferons are of particular importance in MS because interferon-beta in humans appears to be protective against autoimmunity associated with MS, and interferon-1b was the first disease- modifying agent for the treatment of relapsing-remitting MS4).